Replies to post #629399 on NorthWest Biotherapeutics Inc (NWBO)

[martyDg]

Looks like Merck tried to lowball nwbo. Around that period they’re the only one who’s close to nwbo.

[jon_k84]

I have often wondered if this is the reason behind the short campaign. Maybe there's a bad actor in Big Pharma that wants to see if they can get the tech for cheap.

[beartrap12]

Flipper, thanks again for showing us what was, a few months ago, and what is today. What a change seven months makes! Management is now working from a place of strength. Every BP knows DCVax will get approved by MHRA and that approval will cascade to so many other RAs around the globe, and they won't be able to stop it. They have to negotiate with us using larger numbers! Now some BPs will wish they didn't low-ball NWBO!
Thanks!

[Mortimerduke]

Flipper44,
I have grown to look forward to your posts!
Thanks for sticking with this site!

[Astavakra]

I find it noteworthy that LP has gone from speaking of combination trials to combination treatments. IMO, Linda chooses her words extremely carefully. Being months away from approval, would a combo trial even be necessary for DCVax with the exceptional safety profile that it's demonstrated? Experts will correct me if I'm mistaken, I'm certain, but upon approval couldn't clinicians combine treatment with DCVax with another approved treatment of their choice with the patient's consent?

[exwannabe]

Let me give you a little more background.

For seven years NWBO has presented "investors" with a steady stream of trials they were in talks for, planning for and even about to launch.

. The Germany colorectal trial.
. The 3 combo trials with 3 vendors in 3 indications
. The Direct basket P2
. The Direct pediatruc trial
. The Direct brain mets trial

Continually presented as if they would start. And they never did.

And now they are spinning the story again.

P.T. Barnum is laughing his ass off.